
Learn how FDA QMSR impacts 21 CFR 820. Internal audit and management review records are no longer confidential and subject to inspection under the new rule.

Learn how FDA QMSR impacts 21 CFR 820. Internal audit and management review records are no longer confidential and subject to inspection under the new rule.

Analyze the FDA QMSR final rule, ISO 13485 alignment, and the new CP 7382.850 inspection playbook. Learn key compliance steps for device manufacturers.

Analyze the FDA Quality Management System Regulation (QMSR) effective Feb 2, 2026. Learn how ISO 13485:2016 incorporation impacts medical device compliance.

Explore the role of interview discipline in FDA inspections. This analysis covers skill decay causes and how AI tools augment auditor questioning techniques.

Prepare for FDA BIMO inspections with this updated 2026 guide for clinical sites & CROs. Covers ICH E6(R3), finalized BIMO guidance, RRAs, documentation, QMS, staff training, & GCP compliance.

Explore the FDA Pre-license Inspection (PLI) process for biologics. This guide explains the PLI's purpose, scope, cGMP requirements for BLA approval, and the latest 2025-2026 developments including AI-driven inspection targeting, remote assessments, and the BIOSECURE Act.

Learn best practices for writing an effective FDA 483 response. Updated with FY2024-2025 enforcement data and FDA's AI-driven inspection targeting. Covers CAPAs, timelines, and strategies to avoid Warning Letters.
© 2026 IntuitionLabs. All rights reserved.